To access this element change to forms mode OFF
Grant Award View - GA60394
Towards the treatment of Duchenne Muscular Dystrophy
GA ID:
GA60394
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
1-Aug-2019
Publish Date:
4-Nov-2019
Category:
Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2022
Value (AUD):
$541,955.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Development Grants
Grant Activity:
Towards the treatment of Duchenne Muscular Dystrophy
Purpose:
Duchenne muscular dystrophy (DMD) is a debilitating diseased characterised by rapid muscle weakness. There is no cure for DMD. Steroids are prescribed to control symptoms and slow disease progression but have significant side effects. We have developed potent and selective drug candidates that block a key inflammatory pathway which have been shown to reduce muscle damage in mouse models of DMD. We aim to optimize our candidates and ultimately progress them to human clinical trials.
GO ID:
GO Title:
NHMRC Development Grants 2019 for funding in 2020
Internal Reference ID:
GNT1179074
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Queensland
Recipient ABN:
63 942 912 684
Grant Recipient Location
Suburb:
St Lucia
Town/City:
St Lucia
Postcode:
4072
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
QLD
Postcode:
Country:
AUSTRALIA